All Headlines >>
The new spot on, which is complementary to the Bravecto dog chew, is the only one to provide 12 week protection for both fleas and ticks, including Rhipicephalus sanguineus.
The company highlights research it carried out which showed that the convenience of Bravecto's 12 week flea and tick killing treatment improves compliance over monthly alternatives1.
The new product means practices now have more choice if they prefer to offer a spot-on or clients find compliance easier to achieve with a spot-on rather than a chew.
Amanda Melvin, Marketing Manager at MSD Animal Health said: "Our research has shown that convenience is the key to improving compliance and successfully eradicating fleas and ticks. By offering a new formulation of a 12 week treatment, Bravecto Spot-on for dogs further increases the opportunity.
"It improves the choice for vets and pet owners depending on the client’s lifestyle and type of dog.
"This new innovation also offers vets the opportunity to raise the topic of fleas and ticks with clients that have been more reluctant to use existing products.”
The applicator for Bravecto Spot-on for dogs has been designed so there is no need to remove a loose cap and no sharp edges that can scratch the pet's skin.
The launch is also supported by a range of materials for veterinary surgeons, nurses and pet owners, including information guides, a quick-fact flip book, waiting room materials, Bravecto 3+1 card and post-prescription client leaflets.
For more information, contact your MSD Account Manager.
Reference
PS: Whilst you're here, take a moment to see our latest job opportunities for vet nurses.